Literature DB >> 16362769

Problems associated with biological markers of Alzheimer's disease.

H J Frey1, K M Mattila, M A Korolainen, T Pirttilä.   

Abstract

The etiopathogenesis of Alzheimer's disease (AD) is still unclear, although clinical diagnostic criteria exist and the neuropathology of AD has been studied in great detail during the last 20 years. The present study addresses certain problems in the search for biological markers for the diagnosis, as well as in the follow-up of the course of AD and its differential diagnosis and reports some of our own observations in comparison with other studies. These include protein, genetic and neuroimaging markers. The definitions of biological markers and search strategies are also discussed.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16362769     DOI： 10.1007/s11064-005-8827-7

Source DB:  PubMed          Journal:  Neurochem Res        ISSN： 0364-3190            Impact factor:   3.996


  94 in total

1.  Peripheral biomarkers of oxidative damage in Alzheimer's disease: the road ahead.

Authors:  Domenico Praticò
Journal:  Neurobiol Aging       Date:  2005-05       Impact factor: 4.673

2.  Increased plasma amyloid beta protein 1-42 levels in Down syndrome.

Authors:  P D Mehta; A J Dalton; S P Mehta; K S Kim; E A Sersen; H M Wisniewski
Journal:  Neurosci Lett       Date:  1998-01-23       Impact factor: 3.046

Review 3.  Biomarkers in Alzheimer's disease?

Authors:  K M Mattila; H Frey
Journal:  Pathol Biol (Paris)       Date:  1996-10

4.  Isolation and characterization of amyloid P component from Alzheimer's disease and other types of cerebral amyloidosis.

Authors:  F Coria; E Castaño; F Prelli; M Larrondo-Lillo; S van Duinen; M L Shelanski; B Frangione
Journal:  Lab Invest       Date:  1988-04       Impact factor: 5.662

5.  Cerebrospinal fluid beta-amyloid 42 is reduced before the onset of sporadic dementia: a population-based study in 85-year-olds.

Authors:  I Skoog; P Davidsson; O Aevarsson; H Vanderstichele; E Vanmechelen; K Blennow
Journal:  Dement Geriatr Cogn Disord       Date:  2003       Impact factor: 2.959

6.  Protein carbonyl groups as biomarkers of oxidative stress.

Authors:  Isabella Dalle-Donne; Ranieri Rossi; Daniela Giustarini; Aldo Milzani; Roberto Colombo
Journal:  Clin Chim Acta       Date:  2003-03       Impact factor: 3.786

Review 7.  Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease.

Authors: 
Journal:  Neurobiol Aging       Date:  1997 Jul-Aug       Impact factor: 4.673

8.  Comparison of methods for analysis of CSF proteins in patients with Alzheimer's disease.

Authors:  L E Townsend; J Gilroy; P LeWitt; D E Wolfe; N Pomara; J Weintraub; D Reitz
Journal:  Neurochem Pathol       Date:  1987-06

9.  Cytochrome c oxidase is decreased in Alzheimer's disease platelets.

Authors:  Sandra Morais Cardoso; M Teresa Proença; Sancha Santos; Isabel Santana; Catarina R Oliveira
Journal:  Neurobiol Aging       Date:  2004-01       Impact factor: 4.673

Review 10.  Application of proteomics technologies in the investigation of the brain.

Authors:  Michael Fountoulakis
Journal:  Mass Spectrom Rev       Date:  2004 Jul-Aug       Impact factor: 10.946
View more
  10 in total

1.  An internally controlled peripheral biomarker for Alzheimer's disease: Erk1 and Erk2 responses to the inflammatory signal bradykinin.

Authors:  Tapan K Khan; Daniel L Alkon
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-18       Impact factor: 11.205

2.  Role of myo-inositol by magnetic resonance spectroscopy in early diagnosis of Alzheimer's disease in APP/PS1 transgenic mice.

Authors:  Shuang-Qing Chen; Pei-Jun Wang; Gao-Jun Ten; Wei Zhan; Ming-Hua Li; Feng-Chao Zang
Journal:  Dement Geriatr Cogn Disord       Date:  2010-01-06       Impact factor: 2.959

3.  Accumulation of glial fibrillary acidic protein and histone H4 in brain storage bodies of Tibetan terriers with hereditary neuronal ceroid lipofuscinosis.

Authors:  M L Katz; D N Sanders; B P Mooney; Gary S Johnson
Journal:  J Inherit Metab Dis       Date:  2007-11-15       Impact factor: 4.982

4.  Serum-based protein profiles of Alzheimer's disease and mild cognitive impairment in elderly Hispanics.

Authors:  Alcibiades E Villarreal; Sid E O'Bryant; Melissa Edwards; Shantal Grajales; Gabrielle B Britton
Journal:  Neurodegener Dis Manag       Date:  2016-05-27

5.  Analysis of 27 vascular-related proteins reveals that NT-proBNP is a potential biomarker for Alzheimer's disease and mild cognitive impairment: a pilot-study.

Authors:  Josef Marksteiner; Douglas Imarhiagbe; Michaela Defrancesco; Eberhard A Deisenhammer; Georg Kemmler; Christian Humpel
Journal:  Exp Gerontol       Date:  2013-12-10       Impact factor: 4.032

Review 6.  Identifying and validating biomarkers for Alzheimer's disease.

Authors:  Christian Humpel
Journal:  Trends Biotechnol       Date:  2010-10-23       Impact factor: 19.536

7.  Alzheimer's disease: new diagnostic and therapeutic tools.

Authors:  Marco Racchi; Daniela Uberti; Stefano Govoni; Maurizio Memo; Cristina Lanni; Sonya Vasto; Giuseppina Candore; Calogero Caruso; Loriana Romeo; Giovanni Scapagnini
Journal:  Immun Ageing       Date:  2008-08-13       Impact factor: 6.400

8.  Altered proteolysis in fibroblasts of Alzheimer patients with predictive implications for subjects at risk of disease.

Authors:  Alessandra Mocali; Nunzia Della Malva; Claudia Abete; Vito Antonio Mitidieri Costanza; Antonio Bavazzano; Vieri Boddi; Luis Sanchez; Sandra Dessì; Alessandra Pani; Francesco Paoletti
Journal:  Int J Alzheimers Dis       Date:  2014-05-18

9.  A Selection of Important Genes and Their Correlated Behavior in Alzheimer's Disease.

Authors:  Yazeli E Cruz-Rivera; Jaileene Perez-Morales; Yaritza M Santiago; Valerie M Gonzalez; Luisa Morales; Mauricio Cabrera-Rios; Clara E Isaza
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

10.  The Main Alkaloids in Uncaria rhynchophylla and Their Anti-Alzheimer's Disease Mechanism Determined by a Network Pharmacology Approach.

Authors:  Peng Zeng; Xiao-Ming Wang; Chao-Yuan Ye; Hong-Fei Su; Qing Tian
Journal:  Int J Mol Sci       Date:  2021-03-31       Impact factor: 5.923
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.